{
    "ticker": "XGN",
    "name": "Exagen Inc.",
    "description": "Exagen Inc. is a biotechnology company that specializes in the development and commercialization of innovative diagnostic tests and solutions for autoimmune diseases. Founded in 2016 and headquartered in Vista, California, Exagen is dedicated to providing healthcare professionals with accurate and actionable insights to better diagnose and manage patients with complex autoimmune conditions such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company's flagship product, AVISE\u00ae, is a proprietary test that measures specific biomarkers to assist clinicians in making informed decisions regarding patient care. Exagen's commitment to enhancing patient outcomes is reflected in its investment in research and development, which aims to further expand its diagnostic offerings and improve the understanding of autoimmune diseases. By leveraging advanced laboratory technologies and a robust clinical research framework, Exagen strives to empower healthcare providers with the tools necessary for precision medicine in the field of rheumatology. The company's mission is not only to provide high-quality diagnostic solutions but also to contribute to the broader understanding of autoimmune diseases through collaboration with the medical community and ongoing educational initiatives.",
    "industry": [
        "Biotechnology",
        "Diagnostics"
    ],
    "headquarters": "Vista, California, USA",
    "founded": "2016",
    "website": "https://www.exagen.com",
    "ceo": "Ron Cohen",
    "social_media": {
        "twitter": "https://twitter.com/Exagen",
        "linkedin": "https://www.linkedin.com/company/exagen/"
    },
    "investor_relations": "https://investors.exagen.com",
    "key_executives": [
        {
            "name": "Ron Cohen",
            "position": "CEO"
        },
        {
            "name": "Michael D. McGowan",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Diagnostic Tests",
            "products": [
                "AVISE SLE",
                "AVISE RA"
            ]
        }
    ],
    "seo": {
        "meta_title": "Exagen Inc. | Innovative Diagnostics for Autoimmune Diseases",
        "meta_description": "Explore Exagen Inc., a leader in biotechnology focused on diagnostic tests for autoimmune diseases. Learn about our advanced AVISE\u00ae tests and commitment to patient care.",
        "keywords": [
            "Exagen",
            "Autoimmune Diseases",
            "Diagnostics",
            "Biotechnology",
            "AVISE SLE",
            "AVISE RA"
        ]
    },
    "faq": [
        {
            "question": "What does Exagen specialize in?",
            "answer": "Exagen specializes in the development of diagnostic tests for autoimmune diseases."
        },
        {
            "question": "Where is Exagen headquartered?",
            "answer": "Exagen is headquartered in Vista, California, USA."
        },
        {
            "question": "What is the AVISE\u00ae test?",
            "answer": "The AVISE\u00ae test is a proprietary diagnostic test that helps in the diagnosis and management of autoimmune diseases."
        },
        {
            "question": "When was Exagen founded?",
            "answer": "Exagen was founded in 2016."
        }
    ],
    "competitors": [
        "AMGN",
        "ILMN",
        "WST"
    ],
    "related_stocks": [
        "ABT",
        "GILD",
        "BMY",
        "VRTX"
    ]
}